BCG re-vaccination in Malawi: 30-year follow-up of a large, randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

BCG re-vaccination in Malawi: 30-year follow-up of a large, randomised, double-blind, placebo-controlled trial

Published:2021-10 Issue:10 Volume:9 Page:e1451-e1459
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Glynn Judith R,Fielding Katherine,Mzembe Themba,Sichali Lifted,Banda Louis,McLean Estelle,Kanjala Chifundo,Crampin Amelia C,Ponnighaus Jorg M,Warndorff David K,Fine Paul E M

Funder

Bill & Melinda Gates Foundation

Wellcome Trust

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. BCG vaccines: WHO position paper—February 2018;Wkly Epidemiol Rec,2018

2. Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination;Nemes;N Engl J Med,2018

3. Bacillus Calmette–Guérin (BCG) revaccination of adults with latent Mycobacterium tuberculosis infection induces long-lived BCG-reactive NK cell responses;Suliman;J Immunol,2016

4. BCG revaccination boosts adaptive polyfunctional Th1/Th17 and innate effectors in IGRA+ and IGRA- Indian adults;Rakshit;JCI Insight,2019

5. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial;Rodrigues;Lancet,2005

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mark of success: The role of vaccine-induced skin scar formation for BCG and smallpox vaccine-associated clinical benefits;Seminars in Immunopathology;2024-08-26

2. Mapping the existing body of knowledge on new and repurposed TB vaccine implementation: A scoping review;PLOS Global Public Health;2024-08-22

3. Early introduction of IL-10 weakens BCG revaccination's protection by suppressing CD4+Th1 cell responses;2024-08-21

4. Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial;The Lancet Infectious Diseases;2024-06

5. Revisiting Bacille Calmette‐Guérin revaccination strategies: timing of immunization, Mycobacterium tuberculosis and non‐tuberculous mycobacteria infections, strain potency and standardization of randomized controlled trials;Clinical and Translational Discovery;2024-05-23